Interaction of ibogaine with human α3β4-nicotinic acetylcholine receptors in different conformational states

Hugo R. Arias, Avraham Rosenberg, Katarzyna M. Targowska-Duda, Dominik Feuerbach, Xiao Juan Yuan, Krzysztof Jozwiak, Ruin Moaddel, Irving W. Wainer

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

The interaction of ibogaine and phencyclidine (PCP) with human (h) α3β4-nicotinic acetylcholine receptors (AChRs) in different conformational states was determined by functional and structural approaches including, radioligand binding assays, Ca2+ influx detections, and thermodynamic and kinetics measurements. The results established that (a) ibogaine inhibits (±)-epibatidine-induced Ca2+ influx in hα3β4 AChRs with ∼9-fold higher potency than that for PCP, (b) [3H]ibogaine binds to a single site in the hα3β4 AChR ion channel with relatively high affinity (Kd=0.46±0.06μM), and ibogaine inhibits [3H]ibogaine binding to the desensitized hα3β4 AChR with slightly higher affinity compared to the resting AChR. This is explained by a slower dissociation rate from the desensitized ion channel compared to the resting ion channel, and (c) PCP inhibits [3H]ibogaine binding to the hα3β4 AChR, suggesting overlapping sites. The experimental results correlate with the docking simulations suggesting that ibogaine and PCP interact with a binding domain located between the serine (position 6') and valine/phenylalanine (position 13') rings. This interaction is mediated mainly by van der Waals contacts, which is in agreement with the observed enthalpic contribution determined by non-linear chromatography. However, the calculated entropic contribution also indicates local conformational changes. Collectively our data suggest that ibogaine and PCP bind to overlapping sites located between the serine and valine/phenylalanine rings, to finally block the AChR ion channel, and in the case of ibogaine, to probably maintain the AChR in the desensitized state for longer time.

Original languageEnglish
Pages (from-to)1525-1535
Number of pages11
JournalInternational Journal of Biochemistry and Cell Biology
Volume42
Issue number9
DOIs
StatePublished - 1 Sep 2010
Externally publishedYes

Fingerprint

Ibogaine
Nicotinic Receptors
Cholinergic Receptors
Ion Channels
epibatidine
Valine
Phenylalanine
Serine
Phencyclidine
Radioligand Assay
Chromatography
Thermodynamics
Assays

Keywords

  • Conformational states
  • Ibogaine
  • Nicotinic acetylcholine receptors
  • Noncompetitive antagonists
  • Phencyclidine

Cite this

Arias, Hugo R. ; Rosenberg, Avraham ; Targowska-Duda, Katarzyna M. ; Feuerbach, Dominik ; Yuan, Xiao Juan ; Jozwiak, Krzysztof ; Moaddel, Ruin ; Wainer, Irving W. / Interaction of ibogaine with human α3β4-nicotinic acetylcholine receptors in different conformational states. In: International Journal of Biochemistry and Cell Biology. 2010 ; Vol. 42, No. 9. pp. 1525-1535.
@article{808e7e8479204361a548b259be061ccb,
title = "Interaction of ibogaine with human α3β4-nicotinic acetylcholine receptors in different conformational states",
abstract = "The interaction of ibogaine and phencyclidine (PCP) with human (h) α3β4-nicotinic acetylcholine receptors (AChRs) in different conformational states was determined by functional and structural approaches including, radioligand binding assays, Ca2+ influx detections, and thermodynamic and kinetics measurements. The results established that (a) ibogaine inhibits (±)-epibatidine-induced Ca2+ influx in hα3β4 AChRs with ∼9-fold higher potency than that for PCP, (b) [3H]ibogaine binds to a single site in the hα3β4 AChR ion channel with relatively high affinity (Kd=0.46±0.06μM), and ibogaine inhibits [3H]ibogaine binding to the desensitized hα3β4 AChR with slightly higher affinity compared to the resting AChR. This is explained by a slower dissociation rate from the desensitized ion channel compared to the resting ion channel, and (c) PCP inhibits [3H]ibogaine binding to the hα3β4 AChR, suggesting overlapping sites. The experimental results correlate with the docking simulations suggesting that ibogaine and PCP interact with a binding domain located between the serine (position 6') and valine/phenylalanine (position 13') rings. This interaction is mediated mainly by van der Waals contacts, which is in agreement with the observed enthalpic contribution determined by non-linear chromatography. However, the calculated entropic contribution also indicates local conformational changes. Collectively our data suggest that ibogaine and PCP bind to overlapping sites located between the serine and valine/phenylalanine rings, to finally block the AChR ion channel, and in the case of ibogaine, to probably maintain the AChR in the desensitized state for longer time.",
keywords = "Conformational states, Ibogaine, Nicotinic acetylcholine receptors, Noncompetitive antagonists, Phencyclidine",
author = "Arias, {Hugo R.} and Avraham Rosenberg and Targowska-Duda, {Katarzyna M.} and Dominik Feuerbach and Yuan, {Xiao Juan} and Krzysztof Jozwiak and Ruin Moaddel and Wainer, {Irving W.}",
year = "2010",
month = "9",
day = "1",
doi = "10.1016/j.biocel.2010.05.011",
language = "English",
volume = "42",
pages = "1525--1535",
journal = "International Journal of Biochemistry and Cell Biology",
issn = "1357-2725",
number = "9",

}

Interaction of ibogaine with human α3β4-nicotinic acetylcholine receptors in different conformational states. / Arias, Hugo R.; Rosenberg, Avraham; Targowska-Duda, Katarzyna M.; Feuerbach, Dominik; Yuan, Xiao Juan; Jozwiak, Krzysztof; Moaddel, Ruin; Wainer, Irving W.

In: International Journal of Biochemistry and Cell Biology, Vol. 42, No. 9, 01.09.2010, p. 1525-1535.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Interaction of ibogaine with human α3β4-nicotinic acetylcholine receptors in different conformational states

AU - Arias, Hugo R.

AU - Rosenberg, Avraham

AU - Targowska-Duda, Katarzyna M.

AU - Feuerbach, Dominik

AU - Yuan, Xiao Juan

AU - Jozwiak, Krzysztof

AU - Moaddel, Ruin

AU - Wainer, Irving W.

PY - 2010/9/1

Y1 - 2010/9/1

N2 - The interaction of ibogaine and phencyclidine (PCP) with human (h) α3β4-nicotinic acetylcholine receptors (AChRs) in different conformational states was determined by functional and structural approaches including, radioligand binding assays, Ca2+ influx detections, and thermodynamic and kinetics measurements. The results established that (a) ibogaine inhibits (±)-epibatidine-induced Ca2+ influx in hα3β4 AChRs with ∼9-fold higher potency than that for PCP, (b) [3H]ibogaine binds to a single site in the hα3β4 AChR ion channel with relatively high affinity (Kd=0.46±0.06μM), and ibogaine inhibits [3H]ibogaine binding to the desensitized hα3β4 AChR with slightly higher affinity compared to the resting AChR. This is explained by a slower dissociation rate from the desensitized ion channel compared to the resting ion channel, and (c) PCP inhibits [3H]ibogaine binding to the hα3β4 AChR, suggesting overlapping sites. The experimental results correlate with the docking simulations suggesting that ibogaine and PCP interact with a binding domain located between the serine (position 6') and valine/phenylalanine (position 13') rings. This interaction is mediated mainly by van der Waals contacts, which is in agreement with the observed enthalpic contribution determined by non-linear chromatography. However, the calculated entropic contribution also indicates local conformational changes. Collectively our data suggest that ibogaine and PCP bind to overlapping sites located between the serine and valine/phenylalanine rings, to finally block the AChR ion channel, and in the case of ibogaine, to probably maintain the AChR in the desensitized state for longer time.

AB - The interaction of ibogaine and phencyclidine (PCP) with human (h) α3β4-nicotinic acetylcholine receptors (AChRs) in different conformational states was determined by functional and structural approaches including, radioligand binding assays, Ca2+ influx detections, and thermodynamic and kinetics measurements. The results established that (a) ibogaine inhibits (±)-epibatidine-induced Ca2+ influx in hα3β4 AChRs with ∼9-fold higher potency than that for PCP, (b) [3H]ibogaine binds to a single site in the hα3β4 AChR ion channel with relatively high affinity (Kd=0.46±0.06μM), and ibogaine inhibits [3H]ibogaine binding to the desensitized hα3β4 AChR with slightly higher affinity compared to the resting AChR. This is explained by a slower dissociation rate from the desensitized ion channel compared to the resting ion channel, and (c) PCP inhibits [3H]ibogaine binding to the hα3β4 AChR, suggesting overlapping sites. The experimental results correlate with the docking simulations suggesting that ibogaine and PCP interact with a binding domain located between the serine (position 6') and valine/phenylalanine (position 13') rings. This interaction is mediated mainly by van der Waals contacts, which is in agreement with the observed enthalpic contribution determined by non-linear chromatography. However, the calculated entropic contribution also indicates local conformational changes. Collectively our data suggest that ibogaine and PCP bind to overlapping sites located between the serine and valine/phenylalanine rings, to finally block the AChR ion channel, and in the case of ibogaine, to probably maintain the AChR in the desensitized state for longer time.

KW - Conformational states

KW - Ibogaine

KW - Nicotinic acetylcholine receptors

KW - Noncompetitive antagonists

KW - Phencyclidine

UR - http://www.scopus.com/inward/record.url?scp=77955096530&partnerID=8YFLogxK

U2 - 10.1016/j.biocel.2010.05.011

DO - 10.1016/j.biocel.2010.05.011

M3 - Article

C2 - 20684041

AN - SCOPUS:77955096530

VL - 42

SP - 1525

EP - 1535

JO - International Journal of Biochemistry and Cell Biology

JF - International Journal of Biochemistry and Cell Biology

SN - 1357-2725

IS - 9

ER -